Heartbeam Company Insiders
Heartbeam employs about 19 people. The company is managed by 11 executives with a total tenure of roughly 45 years, averaging almost 4.0 years of service per executive, having 1.73 employees per reported executive. Breaking down Heartbeam's management performance can provide insight into the firm performance.
Heartbeam | Build AI portfolio with Heartbeam Stock |
Heartbeam Management Team Effectiveness
The company has return on total asset (ROA) of (1.1327) % which means that it has lost $1.1327 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.0258) %, meaning that it created substantial loss on money invested by shareholders. Heartbeam's management efficiency ratios could be used to measure how well Heartbeam manages its routine affairs as well as how well it operates its assets and liabilities.Heartbeam Workforce Comparison
Heartbeam is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 10,832. Heartbeam adds roughly 19.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Heartbeam Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Heartbeam insiders, such as employees or executives, is commonly permitted as long as it does not rely on Heartbeam's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Heartbeam insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cruickshank Tim over a week ago Acquisition by Cruickshank Tim of 400000 shares of Heartbeam at 2.28 subject to Rule 16b-3 | ||
Branislav Vajdic over a month ago Acquisition by Branislav Vajdic of 10000 shares of Heartbeam subject to Rule 16b-3 | ||
Strome Mark E over three months ago Discretionary transaction by Strome Mark E of tradable shares of Heartbeam subject to Rule 16b-3 | ||
Cruickshank Tim over three months ago Acquisition by Cruickshank Tim of 17647 shares of Heartbeam at 1.7 subject to Rule 16b-3 | ||
De Urioste George over six months ago Disposition of 5000 shares by De Urioste George of Heartbeam at 2.46 subject to Rule 16b-3 | ||
Cruickshank Tim over six months ago Insider Trading | ||
De Urioste George over six months ago Disposition of 1674 shares by De Urioste George of Heartbeam at 2.34 subject to Rule 16b-3 | ||
De Urioste George over six months ago Disposition of 5500 shares by De Urioste George of Heartbeam at 2.31 subject to Rule 16b-3 |
Heartbeam Notable Stakeholders
A Heartbeam stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Heartbeam often face trade-offs trying to please all of them. Heartbeam's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Heartbeam's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Richard Ferrari | Executive Chairman | Profile | |
| Robert Eno | President Officer | Profile | |
| Branislav Vajdic | President, Founder | Profile | |
| FACC MD | Chief Officer | Profile | |
| Timothy Cruickshank | Chief Officer | Profile | |
| Richard Brounstein | CFO Treasurer | Profile | |
| Richa Gujarati | Senior Product | Profile | |
| Kenneth Persen | Chief Officer | Profile | |
| Ken Persen | Chief Officer | Profile | |
| Lance Myers | Chief Scientist | Profile | |
| Jon Hunt | Exec Officer | Profile |
About Heartbeam Management Performance
The success or failure of an entity such as Heartbeam often depends on how effective the management is. Heartbeam management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Heartbeam management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Heartbeam management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company was incorporated in 2015 and is headquartered in Santa Clara, California. Heartbeam operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.
Please note, the imprecision that can be found in Heartbeam's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Heartbeam. Check Heartbeam's Beneish M Score to see the likelihood of Heartbeam's management manipulating its earnings.
Heartbeam Workforce Analysis
Traditionally, organizations such as Heartbeam use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Heartbeam within its industry.Heartbeam Manpower Efficiency
Return on Heartbeam Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1M | |
| Net Loss Per Executive | 1.8M | |
| Working Capital Per Employee | 60.4K | |
| Working Capital Per Executive | 104.4K |
Additional Tools for Heartbeam Stock Analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.